Including China in a Drug Development Program

《Including China in a Drug Development Program》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、FierceBiotech.comFierceBiotechTHEBIOTECHINDUSTRY’SDAILYMONITORChinarepresentsabout20%ofevidenceshowsitisimproving.theworld’spopulationand,afterToovercometheseobstacles,aINCLUDINGCHINAINtheU.S.,ithasthesecond-largestnumberofinternationalCROsandeconomy.Themarketsizeal

2、oneconsultantsaresettingupshopinmakesitanattractivetargetforChina,offeringanythingfromclinicalbiopharmaceuticaldevelopment,butservicestocapitalinvestmentandDRUGDEVELOPMENTdemographicandeconomicchangesstrategicadvice.Therearestilltwomakeitevenmoreso:afast-growingdisti

3、nctlyseparatetiersforCROsinurbanmiddleclass,anagingpopu-China,globalandlocal,butglobalOPPORTUNITIESlation,andwiderhealthinsuranceCROsareworkingtobreakintoPROGRAMS:coverage.thelocalCROmarket.InternationalAlthoughChinahasmanyregu-companiesarealsosettingupstand-&CHALLEN

4、GESlatoryhurdles,China’sregulatoryaloneclinicaltrialcenters,whichagency,theStateFoodandDrugallowthemtoconductclinicaltrialsAdministration(SFDA),hasinitiatedseparatelyfromChina’sdrugdevel-anumberofreformstomakeChinaopmentinfrastructure.amoredesirablecenterforinterna-A

5、lthoughdoingbusinessinChinationaldrugdevelopment.presentsmanychallengesforset-Yetdrugdevelopersfaceobsta-tingupclinicaltrialsandperformingcles.Despiterelativelylowcostsbiopharmaceuticaldevelopment,forclinicaltrials,Chinahasthemostexpertsestimatepharmaceuti-longestdru

6、gapplicationtimelineofcalmarketgrowththereat20%toanyAsiancountry.Therearealso25%overthenextdecade.Withanumberofotherhurdles,whichapopulationexceeding1.3billionincludelanguageandculturalbarrierspeople,alargemiddleclassandanaswellaswhatareoftenperceivedagingpopulation,

7、Chinaoffershugeasinadequateintellectualpropertymarketpotentialforthebiopharma-protections.Therehavebeencriti-ceuticalindustry.lcismsofthequalityoftechnicalandregulatoryexpertise,althoughmostTheEditorsofFierceBiotechTHANKYOUTOOURSPONSOR:3591112151719MarketOpportunity

8、RegulatoryLandscapeIncludingChinainaPartneringWithaMarketAccessOn-the-GroundChinain2020ReferencesDrugDevelopmentCROinChinaConsidera